Antibiotic therapy for ventilator-associated tracheobronchitis
- 1 May 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 21 (3) , 250-259
Abstract
Purpose of review The present review draws our attention to ventilator-associated tracheobronchitis (VAT) as a distinct clinical entity that has been associated with progression to ventilator-associated pneumonia (VAP) and worse patient outcomes. In contrast to VAP, which has been extensively investigated for over the past 30 years, most VAT studies have been conducted in the past decade. There are ample data which demonstrate that VAT may progress to VAP, have more ventilator days, and have longer ICU stay that may translate into higher healthcare costs. Recent findings The article focuses on the diagnostic criteria for VAT, causative agents, and studies analyzing associations between VAT and patient outcomes in relation to early, appropriate intravenous, and/or aerosolized antibiotic therapy. Aerosolized antibiotic treatment delivered by improved device technology is a novel approach that has proved to be effective for the treatment and eradication of multidrug-resistant bacterial pathogens. Aerosolized antibiotics are effective in decreasing the use of systemic antibiotics, reducing bacterial resistance, and may also facilitate clinical resolution of infection. Summary Evidence presented in this review supports treatment of VAT with early and appropriate antibiotic therapy as a standard of care to reduce VAP, ventilator days, and duration of ICU stay in high-risk patient population.Keywords
This publication has 40 references indexed in Scilit:
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled StudyClinical Infectious Diseases, 2012
- Ventilator‐Associated Tracheobronchitis and Pneumonia: Thinking Outside the BoxClinical Infectious Diseases, 2010
- Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: Systematic review and meta-analysisRespiratory Medicine, 2010
- Ventilator-associated infectionCurrent Opinion in Pulmonary Medicine, 2009
- Nosocomial tracheobronchitisCurrent Opinion in Infectious Diseases, 2009
- Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit*Critical Care Medicine, 2008
- Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter studyCritical Care, 2008
- Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: A case–control studyJournal of Infection, 2008
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial InfectionsClinical Infectious Diseases, 2005